The rising incidence of diabetes and metabolic conditions underscores the significance of understanding global trends in diabetes and endocrine disorders. Rapid urbanization, dietary shifts, and sedentary lifestyles contribute to escalating disease prevalence worldwide. Advances in medical research reveal regional variations in genetic predisposition and environmental influences, shaping targeted intervention strategies. The increasing adoption of digital health technologies, such as telemedicine and AI-driven diagnostics, enhances disease management and accessibility in resource-limited settings. Collaborative efforts among governments, healthcare institutions, and research organizations aim to develop cost-effective therapies and preventive measures, addressing the growing burden of diabetes and endocrine disorders on a global scale.
Mahir Khalil Ibrahim Jallo
Gulf Medical University, Canada
Yong Xiao Wang
Albany Medical College, United States
F Buck Willis
University of Belize, Belize
Sujith Rajan
NYU Long Island School of Medicine, United States
Amy Gutman
AdventHealth; Tough Love MD, United States
Paraskevi Theofilou
Hellenic Open University, Greece
Teji S Dhami
Boost your Health and Wellness, United StatesSubmit your abstract Today
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters ?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, University of Belize, Belize
Title : Serum fructosamine: A more accurate screening test than 3-hour OGTT for diagnosis of gestational diabetes
Sarah Exley, Broadlawns Medical Center, United States